The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.60
Bid: 2.50
Ask: 2.70
Change: -0.20 (-7.14%)
Spread: 0.20 (8.00%)
Open: 2.85
High: 2.85
Low: 2.60
Prev. Close: 2.80
TERN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of General Meeting

17 May 2021 07:00

RNS Number : 7441Y
Tern PLC
17 May 2021
 

17 May 2021

 

Tern Plc

("Tern" or the "Company")

 

Notice of General Meeting

 

Tern Plc (AIM:TERN), the investment company specialising in the Internet of Things ("IoT"), announces that it will send a circular today to shareholders containing a notice convening a general meeting of the Company which is to be held at 10.30 a.m. on 2 June 2021 at the Company's offices at Gridiron, One Pancras Square, London N1C 4AG (the "General Meeting"). The circular will be available shortly on the Company's website at https://www.ternplc.com/aim-rule-26.

 

The General Meeting is being convened following the withdrawal of certain resolutions from the Company's Annual General Meeting ("AGM") held on 4 May 2021. The resolutions to be proposed at the General Meeting (the "Resolutions") relate to the authority to be granted to the directors of the Company (the "Directors") to issue new ordinary shares of 0.02p in the capital of the Company ("Ordinary Shares") and the disapplication of pre-emption rights in relation to such an issue of Ordinary Shares. Following consultation with a number of the Company's larger shareholders and feedback kindly submitted by others, the resolutions have been revised to permit a lower number of Ordinary Shares to be authorised for potential issue by the Directors than was originally sought in the resolutions which were withdrawn at the AGM.

 

Background and reasons for the Resolutions

 

As previously announced, although a majority of the votes received in advance of the AGM were in favour of the resolutions authorising the Directors to issue new Ordinary Shares and disapply pre-emption rights, the Chairman of the AGM, Ian Ritchie, after consultation with the Board, decided to withdraw these resolutions from being voted on at the AGM. The resolutions were withdrawn due to the low number of shareholder votes received and given that, on the basis of the proxy votes cast, resolution numbered 6 (to grant the Directors the authority to issue new Ordinary Shares for cash) would not have achieved the requisite number of votes to be passed.

 

Following the withdrawal of these resolutions at the AGM, the Directors do not currently have the authority to issue any new Ordinary Shares for cash or generally.

 

The Directors believe that having the authority to issue new Ordinary Shares is important for an investment company such as Tern as it:

 

provides the Company with the flexibility to support its portfolio companies as required;

gives the Company negotiating leverage when dealing with potential third-party investors in discussions about the portfolio companies;

enables the Company to participate at short notice in potential fundraisings by its portfolio companies. If this is not possible, the Company could find its shareholdings in its portfolio companies are diluted and/or a lower valuation might be achieved in any such fundraise, which may then adversely impact upon the Company; and

allows the Company to react quickly should an appropriate need for additional capital arise, particularly given the anticipated development pathways of many of the Company's portfolio companies and any appropriate potential investment opportunities that may arise.

 

The Resolutions would permit the Directors to issue up to 50 million new Ordinary Shares (representing approximately 15 per cent. of the Company's existing issued ordinary share capital) generally and for cash whilst disapplying the pre-emption rights of existing shareholders in relation to such an issue.

 

Should the Company seek to raise funds utilising the authorities that would be granted by the Resolutions through the issue of new Ordinary Shares it would use reasonable endeavours to utilise a platform such as PrimaryBid, as part of any offering, to allow retail shareholders the opportunity to participate in such fundraisings at the same price as other participants.

 

General Meeting arrangements

 

In light of the prevailing guidance from the UK Government in relation to the COVID-19 pandemic and specifically the restrictions on unnecessary travel and large gatherings, the General Meeting will be convened with the minimum quorum of shareholders (which will be facilitated by the Company's management) in order to conduct the business of the meeting. Entry to the General Meeting will be refused to any shareholder, proxy or corporate representative (other than those required for a quorum to exist) who attempt to attend the General Meeting in person.

 

The Company will continue to closely monitor the developing impact of COVID-19, including the latest UK Government guidance. Should it become appropriate to revise the current arrangements for the General Meeting, any such changes will be notified to shareholders through the Company's website and, where appropriate, by announcement made by the Company to a Regulatory Information Service. Voting on each resolution at the General Meeting will be by poll and will include all valid proxy votes received.

 

Enquiries

 

Tern Plc

Al Sisto (CEO)

Sarah Payne (CFO)

via IFC Advisory

 

Allenby Capital Limited

(Nominated Adviser and Broker)

David Worlidge / Alex Brearley (Corporate Finance)

Matt Butlin / Kelly Gardiner (Sales and Corporate Broking)

 

Tel: 0203 328 5656

 

IFC Advisory

(Financial PR and IR)

Tim Metcalfe

Graham Herring

Florence Chandler

 

Tel: 0203 934 6630

tern@investor-focus.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOGSFWFMLEFSEEI
Date   Source Headline
25th Apr 20247:00 amRNSExercise of warrants held in Wyld Networks
12th Apr 20247:00 amRNSPlacing to raise £420,000
9th Apr 20247:00 amRNSTalking Medicines record revenue bookings in Q1 24
21st Mar 20247:00 amRNSOnline Investor Presentation and Q&A Session
5th Mar 20247:00 amRNSKonektio Administration
7th Feb 20247:00 amRNSDevice Authority Fund Raise
1st Feb 20247:00 amRNSTalking Medicines Fundraise
31st Jan 20245:32 pmRNSTotal Voting Rights
24th Jan 20247:00 amRNSPlacing to raise £400,000
15th Jan 20243:22 pmRNSHolding(s) in Company
28th Dec 20237:00 amRNSCompletion of Tranche One of the DA Fund raise
27th Dec 20237:00 amRNSDevice Authority Fund raise
29th Nov 20237:00 amRNSKonektio update
24th Nov 20237:00 amRNSInvestor Webinar Recording
21st Nov 20237:00 amRNSCompany and Portfolio Update
15th Nov 20237:00 amRNSOnline Investor Presentation and Q&A Session
8th Nov 20237:00 amRNSKonektio update
26th Sep 202312:19 pmRNSResult of GM
31st Aug 20237:00 amRNSNotice of General Meeting
16th Aug 20237:00 amRNSInterim results for the six months to 30 June 2023
10th Aug 20237:00 amRNSBoard and Management Restructuring
4th Aug 20231:33 pmRNSStatement re Share Price Movement
4th Jul 20237:00 amRNSDevice Authority convertible loan note extension
30th Jun 20235:00 pmRNSTotal Voting Rights
29th Jun 202310:09 amRNSResult of AGM and Directorate Change
28th Jun 20237:00 amRNSDevice Authority - Winner of Microsoft Award
12th Jun 202311:35 amRNSFunding facility
31st May 20237:00 amRNSResults for the year ended 31 December 2022
26th May 20237:00 amRNSKonektio Fundraise
23rd May 20237:00 amRNSNotice of Final Results & Investor Q&A Session
25th Apr 20237:00 amRNSKonektio Fundraise
18th Apr 20237:00 amRNSPortfolio Update and Investor Presentation
31st Mar 20239:00 amRNSWyld Networks Q4 2022 Interim Report
13th Mar 20237:45 amRNSWyld Networks SEK 9.2 million Purchase Order
13th Mar 20237:00 amRNSStatement regarding Silicon Valley Bank
10th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20238:49 amRNSInvestor webinar recording
7th Feb 20237:00 amRNSOnline Investor Presentation and Q&A Session
2nd Feb 202311:08 amRNSProposed Wyld Networks Directorate Change
25th Jan 20237:00 amRNSPortfolio Update & Investor Presentation
12th Jan 20237:30 amRNSWyld Networks SEK 12.6 million Purchase Order
30th Dec 20221:00 pmRNSTotal Voting Rights
22nd Dec 20222:31 pmRNSFurther re. Wyld Networks Warrant Exercise
22nd Dec 20227:00 amRNSKonektio Secondment
21st Dec 20223:14 pmRNSHolding(s) in Company
13th Dec 20227:00 amRNSWyld Networks Warrant Exercise
8th Dec 20227:45 amRNSLaunch of Wyld Networks Satellite IoT Network
8th Dec 20227:00 amRNSSubscription to raise £1.5 million
2nd Dec 20227:00 amRNSDevice Authority Contract Wins
30th Nov 20227:45 amRNSWyld Networks Q3 2022 Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.